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1. Introduction 
The stimulation of glycogenolysis and gluconeo- 
genesis by a-adrenergic agonists in liver may be asso- 
ciated with a transient increase in the concentration 
of cytoplasmic Ca2+ (see [ 11). Some uncertainty 
appears to exist as to the source of this Ca2’ (cf. 
[2-4] and [5,6]), although the ability of mitochon- 
dria of participate in the sequestration of this pulsed 
Ca2+ now seems established [7]. 
In view of the apparent involvement of calmodulin 
in numerous Ca’+dependent metabolic events [g-lo], 
it seemed important to consider whether a-adrenergic 
agonist-induced changes in liver metabolism involve 
this protein. This study, using the perfused rat liver 
system, provides evidence that trifluoperazine, an 
agent used to assess the action of calmodulin [8,9,11], 
antagonises the o-adrenergic agonist-induced stimula- 
tion of glucose output, oxygen consumption and 
mitochondrial Ca2+ fluxes. 
2. Methods 
Livers from female Wistar strain albino rats 
(-200 g body wt) were perfused with Krebs-Henseleit 
bicarbonate medium equilibrated with 95% 02--5% CO* 
essentially as in [ 121. Minor modifications were the 
use of a non-recirculating medium at 32°C [ 131 con- 
taining 1.65 mM CaC12. The flow rate was maintained 
at 15 ml/100 g body wt. The effluent medium was 
monitored for oxygen content using a Rank oxygen 
electrode, and the flow rate through the liver deter- 
mined by measuring the volume of the effluent 
collected in a fixed time. Glucose released by the 
liver was estimated using the glucose oxidase method 
(Sigma assay kit 5 10-A). ‘Heavy’ mitochondria [ 141 
were isolated from separate lobes at 0-4°C. Each 
lobe was completely homogenised within 10 s of its 
removal from the intact organ. Measurement of 
mitochondrial Ca2+ influx, Ca2+ retention and the 
protonmotive force was as in [7,15,16]. Mitochon- 
drial protein was determined as in [ 171. All reagents 
were of analytical reagent grade. Hormones were 
purchased from the Sigma Chemical Co., St Louis, 
MO. Trifluoperazine was a generous gift of Smith, 
Kline and French. 
3. Results 
Fig.1. shows the effect of phenylephrine on 
glucose output and oxygen consumption by the livers 
of fed rats, pre-perfused for 10-I 5 min with or 
without trifluoperazine (3.5 X 10e6 M). Data in 
fig. 1 a indicate that the output of glucose from liver 
is enhanced immediately following the administra- 
tion of phenylephrine (2 X 10m6 M). Such output 
is maximal by -2 min and continues for the duration 
of the experiment. The data also show that pre-per- 
fusion of the liver for 10 min with trifluoperazine 
reduces this response to phenylephrine by -80%. 
Oxygen consumption by the liver increases imme- 
diately following infusion of phenylephrine to reach 
maximal values by -2 min and continues for at least 
7 min (fig.1 b). This response is diminished in magni- 
tude by -50% in the presence of trifluoperazine. 
By contrast, glucagon administration induced 
slower responses in respect of both glucose output 
and oxygen consumption and these were unaffected 
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Fip.1. Effect of triffuaperazine on phenylephrine-induced glucose release and oxygen output in perfused rat liver. Livers of fed 
rats were perfused initially for 5 min with oxygenated Krebs-Henseleit buffer as in section 2. Trifluoperazine (3.5 X 10m6 M) was 
then infused where indicated and 15 min later, phenylephrine (2 X 10m6 M) was infused for a further 7 min. Glucose release (A) 
was estimated by collecting 600 J samples of the effluent medium, removing any conta~nat~~g erythrocytes by centrifugation, 
and assaying portions (50-200 j.d) of the supernatant. The amount of glucose release prior to phenyle~h~e infusion was 0.4-0.8 n&i, 
Oxygen consumption (B) was estimated from the difference between influent and effluent oxygen concentrations. The amount 
of oxygen consumed prior to infusion of phenylephrine was 300-500 PM. Results shown are the mean of 5 separate xpt. (0) 
Trifluoperazine infused; (0) trifluoperazine absent. 
by ore-~rfusio~ with the cafmodulin inhibitor (not 
shown). 
Fig.Za shows the mean of 5 individual expt. in 
which Ca” influx was determined in mitochondria 
isolated from the lobes of livers perfused with or 
without phenylephrine. The initial rate of Ca2+ trans- 
port is stimulated -80% over that of the control (cf. 
171). Fig.2b shows that perfusion of the liver with 
trifluoperazine itself does not alter the control rate 
of Ca2+ influx but completely prevents the stimula- 
tion induced by the hormone. Similar effects of the 
&-agonist and tri~uoperazine were observed on mito- 
chondrial Ca3+ influx when the initid [Ca’*j was 
reduced to 5 gM. Perfusion with glucagon did not 
alter initial rates of Ca’* influx, and pretreatment of
livers with trifluoperazine was without effect (not 
shown). 
The time for which mitochondria were able to 
retain a fixed amount of Ca2+ [ 151 was also increased 
foliowing pre-perfusion for 7 min with 2 X 10” M 
phenylephrine (3.5 f 0.3 vs 6.9 4 0.9 min, n = 4). 
Trifluoperazinc 3.5 X 10” M) exerted effects similar 
to those described above for Ca= influx. The cal- 
mod&n inhibitor had no effect on Ca* retention 
alone but inhibited the effect of phenylephrine by 
39 * 14% (n = 4). 
In some experiments he components of the pro- 
tonmotive force, the mitochondrial transmembrane 
pH gradient and membrane potential, were also deter- 
mined since these parameters are indicators of both 
the functional integrity of the organelie and under 
some conditions, of the capacity of the mitochondria 
to sequester and retain Ca”’ [7,18]. The transmem- 
brane pH gradient and membrane potential of mito- 
chondria prepared from Iivers perfused for 7 min with 
phe~y~eph~ne (2 X 1 O4 M) (see figd), is increased by 
27 Lt: 6% and 3 + 0.5% (n = 3), respectively, when com- 
pared to their appropriate controls (control transmem- 
brane pH gradient, 75.3 It 1.7 mV (n = 3); membrane 
potential, 139.6 +_ 2.8 mV (12 = 3). 
By contrast, pre-perfusion of livers with glucagon 
or trifluoperazine alone had no effect on the mito- 
chondrial transmembrane pHgradient or the mem- 
brane potential in subsequently prepared mitochon- 
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Fig.2. Effect of trifluoperazine on phenylephrine-induced stimulation of the initial rate of mitochondrial Ca*+ influx. Livers of 
fed rats were perfused as indicated in fig.1 and section 2. Prior to infusing phenylephrine, the median lobe was removed, 
homogenised, and the mitochondria isolated. The liver was allowed to recover for 3 min, and then phenylephrine was infused 
into the remaining lobes for 7 min. At this time the papilliform and left main lobes were removed, homogenised and the mito- 
chondria isolated. The initial rate of mitochondrial Ca”+ transport was then measured [7] using 50 /.JM CaCI, containing 0.3 &i 
%ZaW. In (A) trifluoperazine was absent. In (B) trifluoperazine (3.3 X 10e6 M) was infused for 15 min prior to the infusion of 
phenylephrine. R sults shown are the mean of 5 separate xpt. (o,A) refer to mitochondria isolated from median lobes. (*,A.) 
mitochondria isolated from pap~iform and left main lobes. 
dria. Pre-perfusion of livers with trifluoperazine prior 
to administration of phenylephrine, however, reduced 
the stimulatory effect of the a-agonist on the trans- 
membrane pH gradient by 52 f 8% (n = 3). 
4. Discussion 
~enothiazine antipsychotic agents uch as trifluo- 
perazine have been used in a number of studies to 
assess the potential evolvement of calmodulin in 
intracellular Ca2+dependent reactions [8,11,19,20]. 
Experiments in this report establish that pre-perfusion 
of rat liver with trifluoperazine, antagonises the 
stimulation by phenylephrine of glucose output and 
oxygen consumption. The studies in [21] indicate 
that the bulk of this oxygen consumption is attri- 
butable to mitochondria, and other workers have 
observed that several mitochondrial energy-linked 
reactions are sensitive to prior hormone treatment of 
the intact tissue [22-25 J. Here we show that trifluo- 
perazine also ~tagoni~s the stimulation of the pro- 
tonmotive force induced by phenylephrine. The data 
also confirm our findings that atadrenergic agonists 
stimulate mitochondrial Ca2+ influx [7], an effect 
we show here to be antagonised by the calmodulin 
inhibitor. 
On the other hand, trifluoperazine failed to antag- 
onise glucagoninduced metabolic hanges in the 
perfused liver. This, as well as its inability to alter the 
protonmotive force in the sub~~uently isolated 
mitochondria, provides upport for a specific action 
of the i~ibitor. The data also support he view that 
tu-adrenergic agonists act through a mechanism differ- 
ent from that of ghrcagon [26,27]. 
Finally, if one assumes that trifluoperazine specif- 
ically inhibits the action of calmodulin, then some of 
the physiological responses of oadrenergic agonists 
must involve calmodulin. Since one of these early 
responses i a redistribution of cytoplasmic Ca2+ 
[l-7,26,27], it is of some interest hat trifluoperazine 
also antagonises phenyleph~ne-induced stimulation 
of mitochondrial Ca2+ transport. Thus calmodulin 
appears to be involved in the mech~ism of action 
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of the a-adrenergic agonists, and may be a regulator 
q,f mitochondrial Ca2+ fluxes in liver. The interrela- 
tionships of these calmodulin*mediated events is 
currently under further investigation. 
We are grateful to Mr M. Arundel for his assistance 
in carrying out these experiments. This work was 
supported by a grant from the National Health and 
Medical Research Council of Australia. 
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